DERMAPHARM HOLDING SE (DMP.DE) Stock Analyst Earnings Estimates
FRA:DMP - Deutsche Boerse Ag - DE000A2GS5D8 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 942.912M 18.78% | 1.025B 8.68% | 1.135B 10.79% | 1.2B 5.69% | 1.248B 4.00% | 1.3B 4.17% | 1.318B 1.38% | 1.373B 4.17% | 1.426B 3.86% | 1.475B 3.44% | |
| EBITDA YoY % growth | 340.732M 82.46% | 378.35M 11.04% | 302.764M -19.98% | 312.8M 3.31% | 332.37M 6.26% | 351.1M 5.64% | 344.92M -1.76% | 320.62M -7.05% | 420.88M 31.27% | 437.74M 4.01% | |
| EBIT YoY % growth | 295.48M 106.78% | 283.441M -4.07% | 200.992M -29.09% | 210.16M 4.56% | 231.52M 10.16% | 248.69M 7.42% | 257.23M 3.43% | 273.56M 6.35% | 288.87M 5.60% | 304.18M 5.30% | |
| Operating Margin | 31.34% | 27.66% | 17.70% | 17.51% | 18.55% | 19.13% | 19.52% | 19.92% | 20.26% | 20.62% | |
| EPS YoY % growth | N/A 127.27% | N/A -9.92% | N/A -36.10% | 2.04 -9.07% | 2.34 15.01% | 2.60 11.22% | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 1.15 173.81% | 0.99 | 0.16 | 16.19% |
| Q2 2021 Q2Q % growth | 0.74 236.36% | % | ||
| Q1 2021 Q2Q % growth | 0.67 | 0.60 | 0.07 | 12.43% |
| Q4 2020 Q2Q % growth | -66.45% | 0.52 | % | |
| Q3 2020 Q2Q % growth | 0.42 16.67% | 0.43 | -0.01 | -3.29% |
| Q2 2020 Q2Q % growth | 0.22 -42.11% | 0.38 | -0.16 | -42.68% |
| Q3 2019 Q2Q % growth | 0.36 | 0.44 | -0.08 | -18.99% |
| Q2 2019 Q2Q % growth | 0.38 | 0.44 | -0.06 | -14.49% |
| Q1 2019 Q2Q % growth | 0.36 | 0.44 | -0.08 | -18.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 311.602M 9.54% | % | ||
| Q2 2024 Q2Q % growth | 279.802M 6.40% | % | ||
| Q1 2024 Q2Q % growth | 298.691M -6.40% | % | ||
| Q4 2023 Q2Q % growth | 268.798M -7.48% | % | ||
| Q3 2023 Q2Q % growth | 284.466M 8.10% | % | ||
| Q2 2023 Q2Q % growth | 262.969M 9.81% | % | ||
| Q1 2023 Q2Q % growth | 319.118M 37.76% | % | ||
| Q4 2022 Q2Q % growth | 290.517M 6.53% | % | ||
| Q3 2022 Q2Q % growth | 263.139M 8.54% | % | ||
| Q2 2022 Q2Q % growth | 239.479M 11.11% | % | ||
| Q1 2022 Q2Q % growth | 231.641M 9.16% | % | ||
| Q4 2021 Q2Q % growth | 272.716M 25.88% | % | ||
| Q3 2021 Q2Q % growth | 242.446M 21.85% | 248.76M | -6.314M | -2.54% |
| Q2 2021 Q2Q % growth | 215.538M 16.05% | 216.65M | -1.112M | -0.51% |
| Q1 2021 Q2Q % growth | 212.211M 10.26% | 219.51M | -7.299M | -3.33% |
| Q4 2020 Q2Q % growth | 216.655M 18.20% | 213.35M | 3.305M | 1.55% |
| Q3 2020 Q2Q % growth | 198.978M 7.90% | 205.03M | -6.052M | -2.95% |
| Q2 2020 Q2Q % growth | 185.727M 9.50% | 189.22M | -3.493M | -1.85% |
| Q1 2020 Q2Q % growth | 192.469M 17.68% | % | ||
| Q4 2019 Q2Q % growth | 183.302M | 168.42M | 14.882M | 8.84% |
| Q3 2019 Q2Q % growth | 184.406M | 172.51M | 11.896M | 6.90% |
| Q2 2019 Q2Q % growth | 169.619M | 171.7M | -2.081M | -1.21% |
| Q1 2019 Q2Q % growth | 163.553M | 163.62M | -67K | -0.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0.05% |
| Revenue | N/A | N/A | 0% | 1.52% |